百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


百家乐官网破解秘籍| 百家乐的保单打法| 百家乐官网赌术大揭秘| 全讯网财运| 百家乐官网破解| 皇冠网vip小说| 百家乐系列抢庄龙| 真人百家乐官网赌城| 大发888官网sscbcgsesb| 百家乐打庄技巧| 百家乐官网那个平台信誉高| 百家乐官网网址是多少| 大发888网页登陆| 将军百家乐的玩法技巧和规则| 百家乐官网翻天百度影音| 足球直播| 百家乐游戏源码手机| ez百家乐技巧| 传奇百家乐的玩法技巧和规则| 大发888网页免费游戏| 大发888客服咨询电话| 威尼斯人娱乐城官方网址| 网络百家乐真假| 百家乐投注网站是多少| 筹码币百家乐官网麻将| 现金百家乐官网网上娱乐| 澳门百家乐官网才能| 网络足球投注| 宝丰县| 百家乐官网分析软体| 江津市| 六合彩开码结果| 百家乐官网注码调整| 百家乐官网博彩技巧视频| 诸子百家乐官网的玩法技巧和规则| 百家乐娱乐城游戏| 百利宫百家乐的玩法技巧和规则| 大连棋牌网| 澳门博彩| 百家乐官网开户送百元| 福布斯百家乐官网的玩法技巧和规则 |